Italy - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Italy Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry rose 5.3% year on year. With $894,380,465.38 Million PPP in 2019, the country was ranked number 11 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Italy is overtaken by France, which was ranked number 10 with $1,080,008,891 Million PPP and is followed by Sweden with $847,585,097.1 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, a growth of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania was the worst growing country at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 894,380,465.38 |
| 2018 | 876,498,450.23 |
| 2017 | 872,722,600.84 |
| 2016 | 841,632,543.73 |
| 2015 | 729,591,533.33 |
How does Italy rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 10 |
#10
France
|
1,080,008,891.00 | 2019 | -0.1 % | +0.4 % | View data | |
| 11 |
#11
Italy
|
894,380,465.38 | 2019 | +2.0 % | +5.3 % | View data | |
| 12 |
#12
Sweden
|
847,585,097.10 | 2019 | -0.1 % | +2.1 % | View data | |